250 related articles for article (PubMed ID: 23840712)
1. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation.
Zhang X; Qu X; Sun YB; Caruana G; Bertram JF; Nikolic-Paterson DJ; Li J
PLoS One; 2013; 8(6):e67471. PubMed ID: 23840712
[TBL] [Abstract][Full Text] [Related]
2. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
5. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
6. (Pro)renin receptor decoy peptide PRO20 protects against adriamycin-induced nephropathy by targeting the intrarenal renin-angiotensin system.
Luo R; Yang K; Wang F; Xu C; Yang T
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F930-F940. PubMed ID: 32865014
[TBL] [Abstract][Full Text] [Related]
7. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
Ning L; Suleiman HY; Miner JH
Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.
Wang J; Hidaka T; Sasaki Y; Tanaka E; Takagi M; Shibata T; Kubo A; Trejo JAO; Wang L; Asanuma K; Tomino Y
Sci Rep; 2018 Nov; 8(1):17157. PubMed ID: 30464326
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
11. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
12. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
13. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
[TBL] [Abstract][Full Text] [Related]
15. Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria.
Liang X; Schnaper HW; Matsusaka T; Pastan I; Ledbetter S; Hayashida T
PLoS One; 2016; 11(5):e0155534. PubMed ID: 27187580
[TBL] [Abstract][Full Text] [Related]
16. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
17. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
19. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 delays podocyte injury due to high glucose.
De Petris L; Hruska KA; Chiechio S; Liapis H
Nephrol Dial Transplant; 2007 Dec; 22(12):3442-50. PubMed ID: 17686813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
